Therapeutic Advances in Cardiovascular Disease

SJR Rank #6,175H-index: 44SJR: 0.862Best quartile: Q2Open AccessAPC: US$2,650Listed in DOAJ

Journal website: aims, scope and author guidelines

Publisher

SAGE Publications Ltd

Country

United Kingdom

Type

journal

SJR by Edition

Subject Categories

Cardiology and Cardiovascular MedicineQ2
Pharmacology (medical)Q2

Areas: Medicine

Most published research topics

Blood Pressure and Hypertension StudiesHeart Failure Treatment and ManagementCoronary Interventions and DiagnosticsAtrial Fibrillation Management and OutcomesRenin-Angiotensin System StudiesAcute Myocardial Infarction ResearchCardiovascular Function and Risk FactorsLipoproteins and Cardiovascular HealthHormonal Regulation and HypertensionCardiac electrophysiology and arrhythmias

Source: OpenAlex

Publication Statistics

Documents per Year

Detailed Information

ISSN

1753-9455, 1753-9447

SJR Best Quartile

Region

Western Europe

Citations per Document (2 years)

3.39

References per Document

23.54

Coverage

2007-2026

Scope

Therapeutic Advances in Cardiovascular Disease delivers the highest quality peer-reviewed open access original research articles, reviews, and scholarly comment on pioneering efforts and innovative studies in the medical treatment of cardiac and circulatory conditions. The journal has a strong clinical and pharmacological focus and is aimed at an international audience of clinicians and researchers in cardiology, circulatory disorders and related disciplines, providing an online forum for rapid dissemination of recent research and perspectives in this area.

Metrics from SCImago Journal Rank 2025. View on SCImago